EP Patent

EP3556401A1 — Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications

Assigned to University of North Carolina at Chapel Hill · Expires 2019-10-23 · 7y expired

What this patent protects

The presently disclosed subject matter relates to nitric oxide-releasing particles for delivering nitric oxide, and their use in biomedical and pharmaceutical applications.

USPTO Abstract

The presently disclosed subject matter relates to nitric oxide-releasing particles for delivering nitric oxide, and their use in biomedical and pharmaceutical applications.

Drugs covered by this patent

Patent Metadata

Patent number
EP3556401A1
Jurisdiction
EP
Classification
—
Expires
2019-10-23
Drug substance claim
No
Drug product claim
No
Assignee
University of North Carolina at Chapel Hill
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.